BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang L, Guo X, Xu X, De Stefano V, Plessier A, Noronha Ferreira C, Qi X. Anticoagulation Favors Thrombus Recanalization and Survival in Patients With Liver Cirrhosis and Portal Vein Thrombosis: Results of a Meta-Analysis. Adv Ther 2021;38:495-520. [PMID: 33155180 DOI: 10.1007/s12325-020-01550-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 19.0] [Reference Citation Analysis]
Number Citing Articles
1 Odriozola A, Puente Á, Cuadrado A, Rivas C, Anton Á, González FJ, Pellón R, Fábrega E, Crespo J, Fortea JI. Portal Vein Thrombosis in the Setting of Cirrhosis: A Comprehensive Review. JCM 2022;11:6435. [DOI: 10.3390/jcm11216435] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Gao F, Wang L, Pan J, Yin Y, Wang J, Xu X, Xu S, Mancuso A, Qi X. Efficacy and safety of thrombolytic therapy for portal venous system thrombosis: A systematic review and meta-analysis. J Intern Med 2022. [PMID: 36208172 DOI: 10.1111/joim.13575] [Reference Citation Analysis]
3 Gao FB, Wang L, Zhang WX, Shao XD, Guo XZ, Qi XS. Successful treatment of acute symptomatic extensive portal venous system thrombosis by 7-day systemic thrombolysis. World J Gastrointest Surg 2022; 14(9): 1082-1085 [DOI: 10.4240/wjgs.v14.i9.1082] [Reference Citation Analysis]
4 Tarar ZI, Farooq U, Kamal F, Nawaz A, Saleem S, Ghous G, Basar O, Chela HK, Tahan V, Daglilar E. Safety of anticoagulation use for treatment of portal vein thrombosis in liver cirrhosis and its effect on hospital-based outcomes: an insight from a US nationwide database. Postgrad Med J 2022:postgradmedj-2022-141915. [PMID: 36008113 DOI: 10.1136/pmj-2022-141915] [Reference Citation Analysis]
5 Pan J, Wang L, Gao F, An Y, Yin Y, Guo X, Nery FG, Yoshida EM, Qi X. Epidemiology of portal vein thrombosis in liver cirrhosis: A systematic review and meta-analysis. European Journal of Internal Medicine 2022. [DOI: 10.1016/j.ejim.2022.05.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang L, Guo X, Shao X, Xu X, Zheng K, Wang R, Chawla S, Basaranoglu M, Qi X. Association of endoscopic variceal treatment with portal venous system thrombosis in liver cirrhosis: a case–control study. Therap Adv Gastroenterol 2022;15:175628482210875. [DOI: 10.1177/17562848221087536] [Reference Citation Analysis]
7 Li Z, Xu WT, Xu XB, Qi XS. Heparins for prevention and treatment of venous thromboembolism in cirrhosis: Research advances. Shijie Huaren Xiaohua Zazhi 2022; 30(9): 381-386 [DOI: 10.11569/wcjd.v30.i9.381] [Reference Citation Analysis]
8 Mcmurry H, Sabile JM, Elstrott B, Chobrutskiy B, Mohinani A, Patel S, Gowda S, Martens K, Shatzel J. Clinical predictors for thrombus progression in cirrhotic patients with untreated splanchnic vein thrombosis. Thrombosis Research 2022. [DOI: 10.1016/j.thromres.2022.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Martens K, McMurry HS, Koprowski S, Hum J, Haraga J, Jou JH, Shatzel JJ. Anticoagulation in Cirrhosis: Evidence for the Treatment of Portal Vein Thrombosis and Applications for Prophylactic Therapy. J Clin Gastroenterol 2022. [PMID: 35537133 DOI: 10.1097/MCG.0000000000001713] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Biolato M, Paratore M, Di Gialleonardo L, Marrone G, Grieco A. Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis: What is the evidence? World J Hepatol 2022; 14(4): 682-695 [DOI: 10.4254/wjh.v14.i4.682] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 González-domínguez E, Córdova D, Abad P, González E, González C, Cordero JJ. Trastornos de la coagulación en cirrosis hepática: artículo de revisión. Hepatología 2022. [DOI: 10.52784/27112330.145] [Reference Citation Analysis]
12 Guerrero A, Téllez L, Albillos A. Anticoagulation for Portal Vein Thrombosis in Cirrhosis: An Evidence-Based Approach to When and How. Portal Hypertension VII 2022. [DOI: 10.1007/978-3-031-08552-9_24] [Reference Citation Analysis]
13 Nery F. Portal Vein Thrombosis in Patients with Cirrhosis. Vascular Disorders of the Liver 2022. [DOI: 10.1007/978-3-030-82988-9_8] [Reference Citation Analysis]
14 Roberts LN. Rebalanced hemostasis in liver disease: a misunderstood coagulopathy. Hematology Am Soc Hematol Educ Program 2021;2021:485-91. [PMID: 34889414 DOI: 10.1182/hematology.2021000283] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Rupoli S, Fiorentini A, Morsia E, Svegliati-Baroni G, Micucci G, Maroni L, Garvey KB, Fiorentini A, Riva A, Da Lio L, Benedetti A, Offidani M, Olivieri A, Giuseppe T. Anticoagulation and Vessel Recanalization in Cirrhotic Patients with Splanchnic Vein Thrombosis: A Multidisciplinary "Real Life" Experience. Vasc Health Risk Manag 2021;17:619-29. [PMID: 34594107 DOI: 10.2147/VHRM.S310615] [Reference Citation Analysis]
16 Xu S, Guo X, Yang B, Romeiro FG, Primignani M, Méndez-Sánchez N, Yoshida EM, Mancuso A, Tacke F, Noronha Ferreira C, De Stefano V, Qi X. Evolution of Nonmalignant Portal Vein Thrombosis in Liver Cirrhosis: A Pictorial Review. Clin Transl Gastroenterol 2021;12:e00409. [PMID: 34597281 DOI: 10.14309/ctg.0000000000000409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Yeoh SW, Kok HK. Transjugular intrahepatic portosystemic shunts in portal vein thrombosis: A review. J Dig Dis 2021. [PMID: 34323378 DOI: 10.1111/1751-2980.13035] [Reference Citation Analysis]
18 Li H, Sun PM, Sun HW, Cui Y. Progress in clinical diagnosis and treatment of cavernous transformation of the portal vein. Shijie Huaren Xiaohua Zazhi 2021; 29(12): 662-669 [DOI: 10.11569/wcjd.v29.i12.662] [Reference Citation Analysis]
19 Mancuso A. Controversies in the Management of Portal Vein Thrombosis in Liver Cirrhosis. J Clin Med 2020;9:E3916. [PMID: 33276635 DOI: 10.3390/jcm9123916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]